# US 6,730,492 B2 · Cell-based screening methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,492 B2
- Document ID: US6730492B2
- Status: Granted
- Kind: B2
- Application number: 10/093,945
- Filed: 2002-03-09
- Published: 2003-09-11
- Granted: 2004-05-04
- Earliest claimed: 2002-03-09
- Assignees: Merrimack Pharmaceuticals, Inc.
- Inventors: Michael H. Cardone; Michael Yaffe
- Web page: https://patentgrep.com/patent/US6730492B2

## CPC

- C12Q 1/25: involving enzymes not classifiable in groups C12Q1/26 {- C12Q1/66}
- C12Q 1/485: {involving kinase}
- G01N 2500/00: Screening for compounds of potential therapeutic value
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Cell-based screening methods for determining kinase activity are provided. The methods utilize existing cellular pathways that are regulated by kinases. In one embodiment, various components of a ubiquitin-mediated degradation pathway are modified to create an assay that can be used to screen for a molecule that modulates the activity of a kinase of interest that otherwise does not regulate the degradation pathway. In another embodiment, various components of a protein translocation pathway are modified to screen for a molecule that modulates the activity of a kinase of interest that otherwise does not regulate the translocation pathway.

## Claims

### Claim 1

A fusion protein comprising a genetically altered signaling enzyme and a label, said signaling enzyme comprising, in its unaltered state, an E3 ubiquitin ligase (E3 ligase), said alteration producing an adapter module in said signaling enzyme capable of binding to a phosphorylation substrate that said enzyme does not bind in its unaltered state, said binding being regulated by a kinase.

### Claim 2 (depends on 1)

The fusion protein of claim 1 wherein said module is disposed at the carboxy terminus of said E3 ligase.

### Claim 3 (depends on 1)

The fusion protein of claim 1 wherein said E3 ligase is an SKP1-Cdc53/Cullin-F-box protein (SCF).

### Claim 4 (depends on 3)

The fusion protein of claim 3 wherein said SCF is a TrCP.
